Outcome measures can be classified into measures of impairment, disability, and handicap. To investigate the biological effect of treatment, measures of impairment are appropriate. Studies investigating whether patients benefit from treatment in terms of improvement of functional health, however, require disability or handicap measures.
of five studies in a mixed group of patients, and in all eight studies in patients with Guillain-Barre syndrome. The limited use of disability and handicap measures in patients with diabetic and mixed neuropathies can be explained by the experimental nature of most studies. In four of six studies, however, in patients with chronic inflammatory demyelinating polyneuropathy or neuropathy associated with monoclonal gammopathy that were designed to assess effectiveness of treatment, the choice of outcome measures was not appropriate. It is concluded that in the design of intervention studies in patients with peripheral neuropathy more attention should be paid to a proper choice of suitable outcome measures to assess the effectiveness of treatment. ( We ordered the outcome measures used in these studies into pathology, impairment, disability, handicap, and subjective health.
Pathology was defined as an abnormality of macroscopic, microscopic, or biochemical structure occurring within the cells of an organ or organ system. This definition is 
